🇺🇸 FDA
Patent

US 6011055

Treatment of cystic disease with compounds which stimulate TNF-.alpha. production in vivo

expired A61KA61K31/192A61K31/404

Quick answer

US patent 6011055 (Treatment of cystic disease with compounds which stimulate TNF-.alpha. production in vivo) held by The Regents of the University of California expires Mon Dec 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/192, A61K31/404, A61K31/405, A61K31/4745